In accordance, our NASH model showed enhanced HSC contraction, correlated with increased αSMA (pro-contractile marker) expression, and this was also reversed by oral administration of atorvastatin. This evidence concerns the gene ACTA1 and metabolic dysfunction-associated steatohepatitis.